Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.
Global In Vitro Diagnostic (IVD) Products key players include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 50 percent.
In terms of product, Immuno Diagnostics is the largest segment, with a share over 20%. And in terms of application, the largest application is Hospitals, followed by Laboratory.
The global In Vitro Diagnostic (IVD) Products market was valued at US$ 75730 million in 2020 and is expected to reach US$ 118940 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.
This report focuses on In Vitro Diagnostic (IVD) Products volume and value at the global level, regional level and company level. From a global perspective, this report represents overall In Vitro Diagnostic (IVD) Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global In Vitro Diagnostic (IVD) Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Segment by Application
Hospitals
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
Biomerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
Johnson and Johnson
Qiagen
Myriad Genetics
Wondfo
KHB
DAAN Gene
Leadman Biochemistry
Mindray
BioSino
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.
Global In Vitro Diagnostic (IVD) Products key players include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 50 percent.
In terms of product, Immuno Diagnostics is the largest segment, with a share over 20%. And in terms of application, the largest application is Hospitals, followed by Laboratory.
The global In Vitro Diagnostic (IVD) Products market was valued at US$ 75730 million in 2020 and is expected to reach US$ 118940 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.
This report focuses on In Vitro Diagnostic (IVD) Products volume and value at the global level, regional level and company level. From a global perspective, this report represents overall In Vitro Diagnostic (IVD) Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global In Vitro Diagnostic (IVD) Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Segment by Application
Hospitals
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
Biomerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
Johnson and Johnson
Qiagen
Myriad Genetics
Wondfo
KHB
DAAN Gene
Leadman Biochemistry
Mindray
BioSino
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
